To screen or not to screen patients with an idiopathic venous thrombosis for an occult cancer: Netherlands versus the World: 1-0?

Netherlands Journal of Medicine

Volumn 70, Issue 7, 2012, Pages 296-297

  Nijziel, M R ^a  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; ENDOSCOPY; HUMAN; IDIOPATHIC DISEASE; IDIOPATHIC VENOUS THROMBOSIS; MAMMOGRAPHY; NETHERLANDS; OCCULT CANCER; SCREENING; VEIN THROMBOSIS;

HUMANS; MASS SCREENING; NEOPLASMS, UNKNOWN PRIMARY; RISK FACTORS; VENOUS THROMBOSIS;

EID: 84866371581     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Piccioli A, Prandoni P. Screening for occult cancer in patients with idiopathic venous thromboembolism: yes. J Thromb Haemost. 2003;1:2271-2.
2. Lee AY. Screening for occult cancer in patients with idiopathic venous thromboembolism: no. J Thromb Haemost. 2003;1:2273-4.
3. Piccioli A, Lensing AW, Prins MH, et al. Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial. J Thromb Haemost. 2004;2:884-9.
4. van Doormaal FF, Terpstra W, Van Der Griend R, et al. Is extensive screening for cancer in idiopathic venous thromboembolism warranted? J Thromb Haemost. 2011;9:79-84.
5. Kleinjan A, van Doormaal FF, Prins MH, Buller HR, Otten JJMB. Limitations of screening for occult cancer in patients with idiopathic venous thromboembolism. Neth J Med. 2012:70:311-7.
6. Rondina MT, Wanner N, Pendleton RC, et al. A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism. Thromb Res. 2012;129:22-7.